Oncology
1 drug is in development for AML (Acute Myeloid Leukemia).
- Companies
- 1
- Clinical trials
- 5
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the AML (Acute Myeloid Leukemia) pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| CLN-049 | Cullinan Therapeutics, Inc. (CGEM) |
About this indication
AML (Acute Myeloid Leukemia) context
Oncology·MeSH: Leukemia, Myeloid, Acute (D015470)
Narrower concept of MeSH descriptor Acute Myeloid Leukemia
Frequently asked questions
How many drugs are in development for AML (Acute Myeloid Leukemia)?
BioSniper tracks 1 drug in development for AML (Acute Myeloid Leukemia) across 1 company.
How many clinical trials target AML (Acute Myeloid Leukemia)?
There are 5 clinical trials targeting AML (Acute Myeloid Leukemia) tracked by BioSniper.